enow.com Web Search

Search results

  1. Results from the WOW.Com Content Network
  2. Merck & Co. - Wikipedia

    en.wikipedia.org/wiki/Merck_&_Co.

    Merck & Co., Inc. is an American multinational pharmaceutical company headquartered in Rahway, New Jersey, and is named for Merck Group, founded in Germany in 1668, of which it was once the American arm. The company does business as Merck Sharp & Dohme or MSD outside the United States and Canada. It is one of the largest pharmaceutical ...

  3. Merck Manual of Diagnosis and Therapy - Wikipedia

    en.wikipedia.org/wiki/Merck_Manual_of_Diagnosis...

    The first edition of The Merck Manual was published in 1899 by Merck & Co., Inc. for physicians and pharmacists and was titled Merck's Manual of the Materia Medica. [6] [7] The 192 page book which sold for US $1.00, was divided into three sections, Part I ("Materia Medica") was an alphabetical listing of all known compounds thought to be of therapeutic value with uses and doses; Part II ...

  4. Category:Merck & Co. - Wikipedia

    en.wikipedia.org/wiki/Category:Merck_&_Co.

    Merck & Co. is a former of subsidiary of Merck, and now an independent company. Subcategories. This category has the following 3 subcategories, out of 3 total. B.

  5. Raynor: What Makes Merck an Exceptional Company - AOL

    www.aol.com/news/2013-06-25-raynor-what-makes...

    A director at Deloitte Services LP and co-author of The Three Rules: How Exceptional Companies Think, Michael Raynor joins The Fool to share his findings about what makes a company successful for ...

  6. Merck Index - Wikipedia

    en.wikipedia.org/wiki/Merck_Index

    The first edition of the Merck's Index was published in 1889 by the German chemical company Emanuel Merck and was primarily used as a sales catalog for Merck's growing list of chemicals it sold. [2] The American subsidiary was established two years later and continued to publish it.

  7. Merck & Company - Wikipedia

    en.wikipedia.org/?title=Merck_&_Company&redirect=no

    This page was last edited on 18 November 2004, at 16:30 (UTC).; Text is available under the Creative Commons Attribution-ShareAlike 4.0 License; additional terms may apply.

  8. Merck's Experimental Favezelimab/Keytruda Combo Fails ... - AOL

    www.aol.com/mercks-experimental-favezelimab...

    On Wednesday, Merck & Co Inc (NYSE:MRK) released topline data from the KEYFORM-007 Phase 3 study of the fixed-dose combination of favezelimab and pembrolizumab versus the standard of care for ...

  9. Merck to buy eye-focused drug developer EyeBio for as ... - AOL

    www.aol.com/news/merck-acquire-eye-drug-company...

    (Reuters) -Merck on Wednesday agreed to buy privately held biotech EyeBio for as much as $3 billion, as it looks to diversify its portfolio of experimental drugs with treatments for eye diseases.